Cargando…
Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282066/ https://www.ncbi.nlm.nih.gov/pubmed/32517782 http://dx.doi.org/10.1186/s13075-020-02238-4 |
| _version_ | 1783544057694257152 |
|---|---|
| author | Strand, Vibeke Pope, Janet Tundia, Namita Friedman, Alan Camp, Heidi S. Pangan, Aileen Ganguli, Arijit Fuldeore, Mahesh Goldschmidt, Debbie Schiff, Michael |
| author_facet | Strand, Vibeke Pope, Janet Tundia, Namita Friedman, Alan Camp, Heidi S. Pangan, Aileen Ganguli, Arijit Fuldeore, Mahesh Goldschmidt, Debbie Schiff, Michael |
| author_sort | Strand, Vibeke |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7282066 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72820662020-06-10 Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT Strand, Vibeke Pope, Janet Tundia, Namita Friedman, Alan Camp, Heidi S. Pangan, Aileen Ganguli, Arijit Fuldeore, Mahesh Goldschmidt, Debbie Schiff, Michael Arthritis Res Ther Correction BioMed Central 2020-06-09 2020 /pmc/articles/PMC7282066/ /pubmed/32517782 http://dx.doi.org/10.1186/s13075-020-02238-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Strand, Vibeke Pope, Janet Tundia, Namita Friedman, Alan Camp, Heidi S. Pangan, Aileen Ganguli, Arijit Fuldeore, Mahesh Goldschmidt, Debbie Schiff, Michael Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT |
| title | Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT |
| title_full | Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT |
| title_fullStr | Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT |
| title_full_unstemmed | Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT |
| title_short | Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT |
| title_sort | correction to: upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from select-next |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282066/ https://www.ncbi.nlm.nih.gov/pubmed/32517782 http://dx.doi.org/10.1186/s13075-020-02238-4 |
| work_keys_str_mv | AT strandvibeke correctiontoupadacitinibimprovespatientreportedoutcomesinpatientswithrheumatoidarthritisandinadequateresponsetoconventionalsyntheticdiseasemodifyingantirheumaticdrugsresultsfromselectnext AT popejanet correctiontoupadacitinibimprovespatientreportedoutcomesinpatientswithrheumatoidarthritisandinadequateresponsetoconventionalsyntheticdiseasemodifyingantirheumaticdrugsresultsfromselectnext AT tundianamita correctiontoupadacitinibimprovespatientreportedoutcomesinpatientswithrheumatoidarthritisandinadequateresponsetoconventionalsyntheticdiseasemodifyingantirheumaticdrugsresultsfromselectnext AT friedmanalan correctiontoupadacitinibimprovespatientreportedoutcomesinpatientswithrheumatoidarthritisandinadequateresponsetoconventionalsyntheticdiseasemodifyingantirheumaticdrugsresultsfromselectnext AT campheidis correctiontoupadacitinibimprovespatientreportedoutcomesinpatientswithrheumatoidarthritisandinadequateresponsetoconventionalsyntheticdiseasemodifyingantirheumaticdrugsresultsfromselectnext AT panganaileen correctiontoupadacitinibimprovespatientreportedoutcomesinpatientswithrheumatoidarthritisandinadequateresponsetoconventionalsyntheticdiseasemodifyingantirheumaticdrugsresultsfromselectnext AT ganguliarijit correctiontoupadacitinibimprovespatientreportedoutcomesinpatientswithrheumatoidarthritisandinadequateresponsetoconventionalsyntheticdiseasemodifyingantirheumaticdrugsresultsfromselectnext AT fuldeoremahesh correctiontoupadacitinibimprovespatientreportedoutcomesinpatientswithrheumatoidarthritisandinadequateresponsetoconventionalsyntheticdiseasemodifyingantirheumaticdrugsresultsfromselectnext AT goldschmidtdebbie correctiontoupadacitinibimprovespatientreportedoutcomesinpatientswithrheumatoidarthritisandinadequateresponsetoconventionalsyntheticdiseasemodifyingantirheumaticdrugsresultsfromselectnext AT schiffmichael correctiontoupadacitinibimprovespatientreportedoutcomesinpatientswithrheumatoidarthritisandinadequateresponsetoconventionalsyntheticdiseasemodifyingantirheumaticdrugsresultsfromselectnext |